Safety and Tolerability of Sarecycline for the Treatment of Acne Vulgaris: Results from a Phase III, Multicenter, Open-Label Study and a Phase I Phototoxicity Study.

导出 OA

翻译打印收藏纠错

第一作者： David M,Pariser

第一单位： Dr. Pariser is with the Eastern Virginia Medical School and Virginia Clinical Research, Inc. in Norfolk, Virginia.;Dr. Green is with the George Washington University School of Medicine in Washington, DC.;Dr. Lain is with the Austin Institute for Clinical Research in Pflugerville, Texas.;Drs. Schmitz, Chinigo, and Berk are with Allergan plc in Irvine, California.;Dr. McNamee is with Allergan Biologics Ltd. in Liverpool, United Kingdom.

作者： David M,Pariser ^[1] ; Lawrence J,Green ^[1] ; Edward L,Lain ^[1] ; Carsten,Schmitz ^[1] ; Amy S,Chinigo ^[1] ; Brian,McNamee ^[1] ; David R,Berk ^[1]

作者单位： Dr. Pariser is with the Eastern Virginia Medical School and Virginia Clinical Research, Inc. in Norfolk, Virginia.;Dr. Green is with the George Washington University School of Medicine in Washington, DC.;Dr. Lain is with the Austin Institute for Clinical Research in Pflugerville, Texas.;Drs. Schmitz, Chinigo, and Berk are with Allergan plc in Irvine, California.;Dr. McNamee is with Allergan Biologics Ltd. in Liverpool, United Kingdom. ^[1]

关键词 Acne vulgaris drug-related adverse reactions drug-related side effects sarecycline tetracycline

PMID 32038757

发布时间 2024-07-23

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交